Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells

Allogeneic human cardiac-derived stem/progenitor cells (hCPC) are currently under clinical investigation for cardiac repair. While cellular immune response against allogeneic hCPC could be part of their beneficial-paracrine effects, their humoral immune response remains largely unexplored. Donor-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hocine, Hocine R., Costa, Hicham E. L., Dam, Noemie, Giustiniani, Jerome, Palacios, Itziar, Loiseau, Pascale, Benssusan, Armand, Borlado, Luis R., Charron, Dominique, Suberbielle, Caroline, Jabrane-Ferrat, Nabila, Al-Daccak, Reem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259698/
https://www.ncbi.nlm.nih.gov/pubmed/28117403
http://dx.doi.org/10.1038/srep41125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259698/
https://www.ncbi.nlm.nih.gov/pubmed/28117403
http://dx.doi.org/10.1038/srep41125

Ejemplares similares